ARCHIVES

NCI Plans Preclinical Studies Of Endoxifen, A Tamoxifen Metabolite.

This article is from The Cancer Letter archive.

Vol. 35 No. 31 | August 7, 2009

Download PDF Visit The Full Archive

Related Articles

Report Says Many Cancers Could Be Prevented

February 27, 2009

Pryce Introduces Bill To Reimbuse For Orally Administered Cancer Drugs.

May 4, 2001

Politicians Applaud CPRIT’s New Direction; UT Gives Waiver To MD Anderson’s DePinho

October 26, 2012

NYC Doctor Pays $2.35 Million To Settle False Claims Act Suit Over Radiosurgery Reimbursements

December 5, 2014

HHS Group To Study Policies Affecting Academic Centers

June 20, 1997

AACR Opposes Human Life Bill; ASCO Backs Cancer Act, Reimbursement

May 8, 1981